Ludwig H. Lin, MD, and Michael G.S. Shashaty, MD, MS, discuss acute kidney injury (AKI) biomarkers and whether they are ready for clinical use. Current research, key takeaway points, the history of AKI biomarkers, and challenges to adoption are reviewed.
Dr. Shashaty is an assistant professor of medicine at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, USA.
